<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BIOSHIELD TECHNOLOGIES, INC. FOR THE 3 MONTHS ENDED
DECEMBER 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                         378,655
<SECURITIES>                                    71,750
<RECEIVABLES>                                  326,225
<ALLOWANCES>                                    34,160
<INVENTORY>                                    179,403
<CURRENT-ASSETS>                             1,039,473
<PP&E>                                       1,391,018
<DEPRECIATION>                                  84,877
<TOTAL-ASSETS>                               7,238,268
<CURRENT-LIABILITIES>                        5,387,430
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     7,377,888
<OTHER-SE>                                 (11,771,075)
<TOTAL-LIABILITY-AND-EQUITY>                (4,393,187)
<SALES>                                        268,954
<TOTAL-REVENUES>                               268,954
<CGS>                                          158,504
<TOTAL-COSTS>                                4,645,555
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (4,319,314)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (4,319,314)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (4,319,314)
<EPS-BASIC>                                       (.67)
<EPS-DILUTED>                                        0<F1>
<FN>
<F1>Diluted loss per common share is not disclosed because the effect of the
exchange or exercise of common stock equivalents would be antidilutive.
</FN>